Concepedia

Marian Iwamoto

MI

65

Publications

3.2K

Citations

33

H-Index

1987

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Celerion (United States)

Orlando Clinical Research Center

Covance (United States)

Pharma Medica Research (Canada)

Marian Iwamoto is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1987–2023

65

Publications

65

Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme

Kelem Kassahun, Ian McIntosh, Donghui Cui et al. · Drug Metabolism and Disposition · 2007 · 274 citations

Terminal differentiation and calcification in rabbit chondrocyte cultures grown in centrifuge tubes: regulation by transforming growth factor beta and serum factors.

Yukio Kato, Marian Iwamoto, Tatsuya Koike et al. · Proceedings of the National Academy of Sciences · 1988 · 259 citations · Full text

, , +18

Safety, Tolerability, and Pharmacokinetics of Raltegravir After Single and Multiple Doses in Healthy Subjects

Marian Iwamoto, LA Wenning, AS Petry et al. · Clinical Pharmacology & Therapeutics · 2007 · 169 citations

Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir

Larissa Wenning, William D. Hanley, Diana M. Brainard et al. · Antimicrobial Agents and Chemotherapy · 2009 · 160 citations · Full text

, , +20

A Study to Determine the Effects of Food and Multiple Dosing on the Pharmacokinetics of Vorinostat Given Orally to Patients with Advanced Cancer

Eric H. Rubin, Nancy Agrawal, Evan Friedman et al. · Clinical Cancer Research · 2006 · 113 citations · Full text

Rows per page

1–5 of 65